Company Profile
Liquidia Corporation Stock Price, News & Analysis
- Ticker:
- LQDA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Liquidia is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
74.04 USD (-1.92%)
Close
Last updated: June 23, 2026 at 00:00
6.58B USD
Market cap
Why the stock is moving
LQDA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Liquidia is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Liquidia is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Liquidia follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Liquidia sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
Source: Liquidia Corporation
- 02
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
Source: Liquidia Corporation
- 03
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Source: Liquidia Corporation
- 04
Liquidia Corporation Reports First Quarter 2026 Financial Results
Source: Liquidia Corporation
- 05
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Source: Liquidia Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Liquidia Corporation (LQDA)?
Liquidia Corporation (LQDA) most recently closed at 74.04 USD, a -1.92% move versus the previous session.
What is the market cap of Liquidia Corporation (LQDA)?
Liquidia Corporation currently has a market capitalization of 6.58B USD on BioPharmSignal.
What does Liquidia Corporation do?
Liquidia is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LQDA stock listed?
Liquidia Corporation (LQDA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Liquidia is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Liquidia?
Liquidia is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Liquidia Corporation targeting with Liquidia?
Liquidia is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.